Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes.
Osman A, Otero J, Brizolara A, Waxman S, Stouffer G, Fitzgerald P, Uretsky BF. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Am Heart J. 2004 May; 147(5):e23.